ATOS - Atossa Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-26,960
-26,960
-20,606
-17,828
-17,240
Depreciation & amortization
8
8
23
46.52
52.789
Stock based compensation
6,788
6,788
5,267
3,019
8,844
Change in working capital
-599
-599
-1,156
-111.352
-791.297
Accounts Payable
1,248
1,248
128
1,295
-60.157
Other working capital
-20,787
-20,787
-16,481
-11,580
-9,136
Other non-cash items
-
-
-
938.794
-
Net cash provided by operating activites
-20,760
-20,760
-16,472
-11,570
-9,128
Cash flows from investing activities
Investments in property, plant and equipment
-27
-27
-9
-9.367
-7.625
Purchases of investments
-4,700
-4,700
-
-
-
Net cash used for investing activites
-4,727
-4,727
-9
-9.367
-7.625
Cash flows from financing activities
Common stock issued
0
0
69,668
33,619
-
Other financing activites
-
-
-573
-14.422
-
Net cash used privided by (used for) financing activities
0
0
113,304
38,552
11,337
Net change in cash
-25,487
-25,487
96,823
26,973
2,201
Cash at beginning of period
136,487
136,487
39,664
12,691
10,490
Cash at end of period
111,000
111,000
136,487
39,664
12,691
Free Cash Flow
Operating Cash Flow
-20,760
-20,760
-16,472
-11,570
-9,128
Capital Expenditure
-27
-27
-9
-9.367
-7.625
Free Cash Flow
-20,787
-20,787
-16,481
-11,580
-9,136